Maarten van der Doelen

Appendices

• Van der Doelen MJ , Slootbeek PHJ, Mehra N. Response to comment on “Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer”. Eur J Cancer. 2021;144:395-6. • Van der Doelen MJ , Isaacsson Velho P, Slootbeek PHJ, Pamidimarri Naga S, Bormann M, Van Helvert S, Kroeze LI, van Oort IM, Gerritsen WR, Antonarakis ES, Mehra N. Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer. Eur J Cancer. 2020;136:16-24. • Kuppen MCP, Westgeest HM, van der Doelen MJ , van den Eertwegh AJ, Coenen JL, Aben KK, van den Berg AC, Bergman AM, van den Bosch J, Celik F, Hendriks MP, Lavalaye J, van der Meer S, Polee MB, Somford DM, van Oort IM, Uyl-de Groot CA, Gerritsen WR. Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer. Future Oncol. 2020;16:1371-84. • Van der Doelen MJ , Fransen van de Putte EE, Horenblas S, Heesakkers J. Results of the York Mason procedure with and without concomitant graciloplasty to treat iatrogenic rectourethral fistulas. Eur Urol Focus. 2020;6:762-9. • Van der Doelen MJ , Mehra N, Hermsen R, Janssen MJR, Gerritsen WR, Van Oort IM. Patient selection for radium-223 therapy inpatientswithbonemetastatic castration resistant prostate cancer: new recommendations and future perspectives. Clin Genitourin Cancer. 2019;17:79-87. • Te Dorsthorst MJ, van der Doelen MJ , Farag FF, Martens FMJ, Heesakkers JPFA. Survival of the artificial urinary sphincter in a changing patient profile. World J Urol. 2019;37:899-906. • Van der Doelen MJ , Kuppen MCP, Jonker MA, Mehra N, Janssen MJR, van Oort IM, et al. Radium-223 therapy in patients with advanced castration-resistant prostate cancer with bone metastases: lessons from daily practice. Clin Nucl Med. 2018;43:9 16. • Benoist GE, van der Doelen MJ , Ter Heine R, van Erp NP, Mehra N. A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancer. Br J Clin Pharmacol. 2018;84:1064-7. • Farag FF, van der Doelen MJ , Van Breda HMK, D’Hauwers KWM, Heesakkers JPFA. Decline in artificial urinary sphincter survival in modern practice - do we treat a different patient? Neurourol Urodyn. 2017;36:1350-5. • Van der Doelen MJ , Withagen MIJ, Vierhout ME, Heesakkers JPFA. Results of primary versus recurrent surgery to treat stress urinary incontinence in women. Int Urogynecol J. 2015;26:997-1005.

250